NDC 86084-100 - Ethiqa XR
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86084-100
- Package NDCs from labels
- 86084-100-30
- Manufacturer
- Fidelis Animal Health, Inc.
- Effective date
- 2026-10-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ethiqa XR ® (buprenorphine extended-release injectable suspension) | Fidelis Animal Health, Inc. | 2026-10-06 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86084-100-30 | Ethiqa XR | 3 mL in 1 VIAL, MULTI-DOSE | INJECTION, SUSPENSION, EXTENDED | 3 | 10 | |
| 86084-100-30 | Ethiqa XR | 1 in 1 CARTON | INJECTION, SUSPENSION, EXTENDED | 1 | 10 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POP Detox 6045 | POP DETOX | Professional Complementary Health Formulas | 48e7e23a-014c-4259-a2c9-37127da3ba03 | 2026-01-08 | Warnings | 97C5T2UQ7J |
| Blood Clenz Drops 2012 | BLOOD CLENZ DROPS | Professional Complementary Health Formulas | 80a273da-bce5-4e37-89da-f40db0491e62 | 2026-01-08 | Warnings | 97C5T2UQ7J |
| Cholesterol 1551 | CHOLESTEROL | Professional Complementary Health Formulas | c8f91020-5840-4e8f-a7ab-867c7e11fb63 | 2026-01-08 | Warnings | 97C5T2UQ7J |
| Carduus Combination 9215 | CARDUUS COMBINATION | Professional Complementary Health Formulas | a244de13-836f-49b5-8c7a-d45bde704d78 | 2026-01-08 | Warnings | 97C5T2UQ7J |
| BELBUCA | BUPRENORPHINE HYDROCHLORIDE | BioDelivery Sciences International Inc | bc2b7a3d-72cf-497c-95b0-ba2b71f63c64 | 2026-01-02 | Boxed warning, Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine and Naloxone Sublingual Film | BUPRENORPHINE AND NALOXONE | Alvogen Inc. | 4210afeb-474c-d842-d68e-af7e0021851a | 2026-01-01 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine Hydrochloride | BUPRENORPHINE HYDROCHLORIDE | Hospira, Inc. | 23aa1bb3-cecf-4e62-29bb-48488bb66fc3 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine and Naloxone Sublingual Film | BUPRENORPHINE AND NALOXONE | Redpharm Drug | 2fd16916-95a9-14b5-e063-6294a90a79fa | 2025-12-27 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Zubsolv | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | Orexo US, Inc. | 5f5cfcfe-d52b-49e6-8fe4-550477332dd2 | 2025-12-27 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine HCl | BUPRENORPHINE HCL | Redpharm Drug | 301eaed5-8499-ad95-e063-6294a90a58f5 | 2025-12-23 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Suboxone | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | INDIVIOR INC. | 8a5edcf9-828c-4f97-b671-268ab13a8ecd | 2025-12-22 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine Hydrochloride | BUPRENORPHINE HYDROCHLORIDE | Par Health USA, LLC | 34767dda-ce52-4f98-a45f-bb5cee0cd5e6 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | 56W8MW3EN1 |
| Hepatatox | TRITICUM AESTIVUM, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, GLUTATHIONE, HEPAR SUIS, THYROIDINUM (SUIS), LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, ADRENOCORTICOTROPHIN, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, PHENYL BUTAZONE, PETROLEUM JELLY, PLUMBUM METALLICUM | BioActive Nutritional, Inc | a113a9f1-4792-41a5-8d1b-a6756f356e15 | 2025-12-18 | Warnings | LKG8494WBH |
| Circulopath | ADENOSINUM CYCLOPHOSPHORICUM, ARNICA MONTANA, AURUM MURIATICUM, BARYTA MURIATICA, BORAGO OFFICINALIS, CHOLESTERINUM, CITRUS LIMONUM, HYPOTHALAMUS (BOVINE), KALI IODATUM, LAUROCERASUS, MAGNESIA MURIATICA, NADIDUM, PHASEOLUS, PHOSPHORUS, THYROIDINUM (BOVINE) | Energetix Corporation | 448d5ea0-ca41-487a-8321-38b1667764bd | 2025-12-17 | Warnings | 97C5T2UQ7J |
| Brain Supp | BRAIN SUPPORT | Vitality Works, Inc. | 4be3d5f8-f974-4ed6-ba90-f0ce08a600fe | 2025-12-17 | Warnings | 97C5T2UQ7J |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Redpharm Drug | 374530e2-3b2e-77d7-e063-6394a90a37c9 | 2025-12-11 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Gallcill | CHELIDONIUM MAJUS, BERBERIS AQUIFOLIUM, BERBERIS VULGARIS, DIOSCOREA VILLOSA, CALCAREA SULPHURICA, CUPRESSUS LAWSONIANA, HEPAR SULPHURICA CALCAREUM, CHOLESTERINUM, FEL TAURI, LYCOPODIUM CLAVATUM, MAGNESIA SULPHURICA | Nucleic Products, LLC | faf3ac96-b744-448d-b41a-8370b3ef3c0c | 2025-12-03 | Warnings | 97C5T2UQ7J |
| Buprenorphine | BUPRENORPHINE | Redpharm Drug | 3dd00186-1f1f-642a-e063-6294a90a6d20 | 2025-12-02 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Zilactin Early Relief Cold Sore | BENZYL ALCOHOL | ASCENT CONSUMER PRODUCTS, INC | 42ef8bfa-c4d9-01cf-e063-6394a90ac88a | 2025-11-06 | Warnings | LKG8494WBH |
| Smoflipid | SMOFLIPID | Fresenius Kabi USA, LLC | e0e9d917-ff6f-488e-a6a8-0ad59dd17d80 | 2025-08-15 | Warnings, Adverse reactions | C9H2L21V7U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.